Prescription Drug Marketing Act
OVERVIEW
To protect US consumers against the distribution and sale of improper or counterfeit pharmaceutical products, Congress passed the Prescription Drug Marketing Act (PDMA) of 1987. Specifically, the legislation was enacted to ensure pharmaceutical products purchased by consumers are safe and effective and safeguard the US supply chain from counterfeit, adulterated, misbranded, subpotent, or expired drugs.
Under this legislation, and subsequent supporting guidance and regulations implemented by the US Food and Drug Administration (FDA), pharmaceutical manufacturers and whole distributors are required to proactively validate and annual disclose key licensing and demographic data attributes for all Healthcare Professionals (HCPs) they distribute samples to.
PDMA DATA CAPTURE AND REPORTING REQUIREMENTS
Accountability for manufacturers and distributors under PDMA is broken into two key requirements:

Each drug sample must be captured and tracked with the location, quantity, validate healthcare recipient name, and signature.

The state license of the recipient must be validated for each sample and no fewer than once per calendar year.
The wording of the PDMA leaves some room for interpretation so the ‘once per calendar year’ minimum is often interpreted to mean that if there is no change to a license, the manufacturer will at least record evidence of the validation step once in a given year. Practically speaking, in the time since the passing of the PDMA, technology has progressed to make a ‘once per calendar year’ validation the exception.
This information then must be annually reported to the FDA by April 1st.
To learn more about PDMA regulations, please visit the FDA website: www.fda.gov.

HOW MEDPRO SYSTEMS CAN SUPPORT
We help Life Science and Healthcare companies drive better health outcomes by navigating complexity throughout their compliance and commercial operations.
Through our Medical Professional ID solution, we offer the most accurate, comprehensive, and trusted source of HCP and HCO identifying data, accessible in real-time through a centralized platform that integrates directly with your internal systems.
Leverage our best-in-class data at your fingertips to meet PDMA’s ongoing commercial validation requirements via:




DEMO THE DIFFERENCE
Book a free demo of our best-in-class license validation platform and enjoy a complimentary two-week trial. Plus, we’ll validate any size test file against our dataset, for a no-cost, no obligation data review!